nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—EPHB2—brainstem—narcolepsy	0.0235	0.0324	CbGeAlD
Nilotinib—EPHB2—forebrain—narcolepsy	0.0227	0.0313	CbGeAlD
Nilotinib—CDC42BPB—forebrain—narcolepsy	0.02	0.0277	CbGeAlD
Nilotinib—MAPK8—brainstem—narcolepsy	0.0188	0.0259	CbGeAlD
Nilotinib—MAPK8—forebrain—narcolepsy	0.0181	0.025	CbGeAlD
Nilotinib—EPHB3—brainstem—narcolepsy	0.0155	0.0214	CbGeAlD
Nilotinib—EPHB3—forebrain—narcolepsy	0.0149	0.0206	CbGeAlD
Nilotinib—CDC42BPB—medulla oblongata—narcolepsy	0.0145	0.02	CbGeAlD
Nilotinib—HCK—forebrain—narcolepsy	0.0137	0.019	CbGeAlD
Nilotinib—CDC42BPB—midbrain—narcolepsy	0.0132	0.0183	CbGeAlD
Nilotinib—MAPK8—medulla oblongata—narcolepsy	0.0131	0.0181	CbGeAlD
Nilotinib—EPHA4—brainstem—narcolepsy	0.0129	0.0179	CbGeAlD
Nilotinib—EPHA4—forebrain—narcolepsy	0.0125	0.0172	CbGeAlD
Nilotinib—CA3—forebrain—narcolepsy	0.0123	0.017	CbGeAlD
Nilotinib—MAPK8—midbrain—narcolepsy	0.012	0.0165	CbGeAlD
Nilotinib—MAPK14—brainstem—narcolepsy	0.0119	0.0165	CbGeAlD
Nilotinib—MAPK14—forebrain—narcolepsy	0.0115	0.0159	CbGeAlD
Nilotinib—EPHB6—forebrain—narcolepsy	0.00998	0.0138	CbGeAlD
Nilotinib—BRAF—midbrain—narcolepsy	0.00995	0.0137	CbGeAlD
Nilotinib—HCK—medulla oblongata—narcolepsy	0.00993	0.0137	CbGeAlD
Nilotinib—PDGFRA—forebrain—narcolepsy	0.00946	0.0131	CbGeAlD
Nilotinib—EPHB2—brain—narcolepsy	0.00941	0.013	CbGeAlD
Nilotinib—HCK—midbrain—narcolepsy	0.00907	0.0125	CbGeAlD
Nilotinib—EPHA4—medulla oblongata—narcolepsy	0.00902	0.0125	CbGeAlD
Nilotinib—EPHA8—brain—narcolepsy	0.00902	0.0125	CbGeAlD
Nilotinib—CA7—midbrain—narcolepsy	0.00888	0.0123	CbGeAlD
Nilotinib—MAP2K5—brainstem—narcolepsy	0.00884	0.0122	CbGeAlD
Nilotinib—CA12—forebrain—narcolepsy	0.00873	0.0121	CbGeAlD
Nilotinib—MAPK11—brain—narcolepsy	0.00839	0.0116	CbGeAlD
Nilotinib—CSF1R—forebrain—narcolepsy	0.00833	0.0115	CbGeAlD
Nilotinib—CDC42BPB—brain—narcolepsy	0.00832	0.0115	CbGeAlD
Nilotinib—CA14—medulla oblongata—narcolepsy	0.00809	0.0112	CbGeAlD
Nilotinib—EPHB4—medulla oblongata—narcolepsy	0.00789	0.0109	CbGeAlD
Nilotinib—EPHA3—brain—narcolepsy	0.00788	0.0109	CbGeAlD
Nilotinib—KIT—brainstem—narcolepsy	0.00784	0.0108	CbGeAlD
Nilotinib—TEK—medulla oblongata—narcolepsy	0.00755	0.0104	CbGeAlD
Nilotinib—MAPK8—brain—narcolepsy	0.00752	0.0104	CbGeAlD
Nilotinib—EPHA6—brain—narcolepsy	0.00752	0.0104	CbGeAlD
Nilotinib—CA14—midbrain—narcolepsy	0.0074	0.0102	CbGeAlD
Nilotinib—EPHB6—medulla oblongata—narcolepsy	0.00721	0.00995	CbGeAlD
Nilotinib—EPHB4—midbrain—narcolepsy	0.00721	0.00995	CbGeAlD
Nilotinib—LYN—brain—narcolepsy	0.00694	0.00958	CbGeAlD
Nilotinib—CA1—forebrain—narcolepsy	0.00692	0.00955	CbGeAlD
Nilotinib—TEK—midbrain—narcolepsy	0.0069	0.00952	CbGeAlD
Nilotinib—MAP4K1—brain—narcolepsy	0.00684	0.00944	CbGeAlD
Nilotinib—ABL1—brainstem—narcolepsy	0.00682	0.00942	CbGeAlD
Nilotinib—EPHB6—midbrain—narcolepsy	0.00659	0.0091	CbGeAlD
Nilotinib—TIE1—brain—narcolepsy	0.00652	0.009	CbGeAlD
Nilotinib—BRAF—brain—narcolepsy	0.00625	0.00863	CbGeAlD
Nilotinib—EPHB3—brain—narcolepsy	0.0062	0.00856	CbGeAlD
Nilotinib—MAP2K5—medulla oblongata—narcolepsy	0.00617	0.00851	CbGeAlD
Nilotinib—CSF1R—medulla oblongata—narcolepsy	0.00602	0.00831	CbGeAlD
Nilotinib—HCK—brain—narcolepsy	0.0057	0.00787	CbGeAlD
Nilotinib—ABL2—brain—narcolepsy	0.00566	0.00782	CbGeAlD
Nilotinib—MAP2K5—midbrain—narcolepsy	0.00564	0.00778	CbGeAlD
Nilotinib—CA4—brainstem—narcolepsy	0.0056	0.00773	CbGeAlD
Nilotinib—CA7—brain—narcolepsy	0.00558	0.0077	CbGeAlD
Nilotinib—CSF1R—midbrain—narcolepsy	0.0055	0.00759	CbGeAlD
Nilotinib—KIT—medulla oblongata—narcolepsy	0.00547	0.00754	CbGeAlD
Nilotinib—CA4—forebrain—narcolepsy	0.00541	0.00746	CbGeAlD
Nilotinib—PDGFRB—medulla oblongata—narcolepsy	0.00534	0.00737	CbGeAlD
Nilotinib—EPHA4—brain—narcolepsy	0.00518	0.00715	CbGeAlD
Nilotinib—CA3—brain—narcolepsy	0.00512	0.00706	CbGeAlD
Nilotinib—KIT—midbrain—narcolepsy	0.005	0.00689	CbGeAlD
Nilotinib—PDGFRB—midbrain—narcolepsy	0.00488	0.00673	CbGeAlD
Nilotinib—MAPK14—brain—narcolepsy	0.00478	0.00659	CbGeAlD
Nilotinib—ABL1—medulla oblongata—narcolepsy	0.00476	0.00657	CbGeAlD
Nilotinib—FGR—brain—narcolepsy	0.00476	0.00657	CbGeAlD
Nilotinib—CA14—brain—narcolepsy	0.00465	0.00641	CbGeAlD
Nilotinib—CA2—brainstem—narcolepsy	0.00465	0.00641	CbGeAlD
Nilotinib—EPHB4—brain—narcolepsy	0.00453	0.00625	CbGeAlD
Nilotinib—CA2—forebrain—narcolepsy	0.00448	0.00619	CbGeAlD
Nilotinib—EPHA2—brain—narcolepsy	0.00444	0.00613	CbGeAlD
Nilotinib—ABL1—midbrain—narcolepsy	0.00435	0.006	CbGeAlD
Nilotinib—TEK—brain—narcolepsy	0.00433	0.00598	CbGeAlD
Nilotinib—EPHB6—brain—narcolepsy	0.00414	0.00572	CbGeAlD
Nilotinib—PDGFRA—brain—narcolepsy	0.00393	0.00542	CbGeAlD
Nilotinib—CA4—medulla oblongata—narcolepsy	0.00391	0.00539	CbGeAlD
Nilotinib—CA12—brain—narcolepsy	0.00362	0.005	CbGeAlD
Nilotinib—CA4—midbrain—narcolepsy	0.00357	0.00493	CbGeAlD
Nilotinib—MAP2K5—brain—narcolepsy	0.00354	0.00489	CbGeAlD
Nilotinib—CSF1R—brain—narcolepsy	0.00346	0.00477	CbGeAlD
Nilotinib—CA2—medulla oblongata—narcolepsy	0.00324	0.00447	CbGeAlD
Nilotinib—KIT—brain—narcolepsy	0.00314	0.00433	CbGeAlD
Nilotinib—PDGFRB—brain—narcolepsy	0.00307	0.00423	CbGeAlD
Nilotinib—ABCG2—medulla oblongata—narcolepsy	0.003	0.00414	CbGeAlD
Nilotinib—CA2—midbrain—narcolepsy	0.00296	0.00409	CbGeAlD
Nilotinib—CYP2D6—brainstem—narcolepsy	0.00295	0.00407	CbGeAlD
Nilotinib—CA1—brain—narcolepsy	0.00287	0.00396	CbGeAlD
Nilotinib—CYP2D6—forebrain—narcolepsy	0.00285	0.00393	CbGeAlD
Nilotinib—ABCG2—midbrain—narcolepsy	0.00274	0.00379	CbGeAlD
Nilotinib—ABL1—brain—narcolepsy	0.00273	0.00377	CbGeAlD
Nilotinib—CA4—brain—narcolepsy	0.00224	0.0031	CbGeAlD
Nilotinib—ABCB1—forebrain—narcolepsy	0.00205	0.00283	CbGeAlD
Nilotinib—CA2—brain—narcolepsy	0.00186	0.00257	CbGeAlD
Nilotinib—CYP2C8—brain—narcolepsy	0.00177	0.00245	CbGeAlD
Nilotinib—ABCG2—brain—narcolepsy	0.00172	0.00238	CbGeAlD
Nilotinib—CYP2B6—brain—narcolepsy	0.00159	0.00219	CbGeAlD
Nilotinib—ABCB1—medulla oblongata—narcolepsy	0.00148	0.00204	CbGeAlD
Nilotinib—ABCB1—midbrain—narcolepsy	0.00135	0.00187	CbGeAlD
Nilotinib—CYP2D6—brain—narcolepsy	0.00118	0.00163	CbGeAlD
Nilotinib—ABCB1—brain—narcolepsy	0.00085	0.00117	CbGeAlD
Nilotinib—MAPK11—Immune System—SOCS2—narcolepsy	0.000802	0.00291	CbGpPWpGaD
Nilotinib—MAPK11—Gene Expression—CTNNBL1—narcolepsy	0.000797	0.00289	CbGpPWpGaD
Nilotinib—CA6—Metabolism—CPT1B—narcolepsy	0.000797	0.00289	CbGpPWpGaD
Nilotinib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TNF—narcolepsy	0.000795	0.00288	CbGpPWpGaD
Nilotinib—CA2—Metabolism—CHKB—narcolepsy	0.000775	0.00281	CbGpPWpGaD
Nilotinib—LCK—CXCR4-mediated signaling events—HLA-DRB1—narcolepsy	0.000771	0.0028	CbGpPWpGaD
Nilotinib—CA7—Metabolism—CPT1B—narcolepsy	0.000744	0.0027	CbGpPWpGaD
Nilotinib—CA1—Metabolism—CHKB—narcolepsy	0.000743	0.0027	CbGpPWpGaD
Nilotinib—MAPK8—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.000741	0.00269	CbGpPWpGaD
Nilotinib—MAPK14—TWEAK Signaling Pathway—TNF—narcolepsy	0.000733	0.00266	CbGpPWpGaD
Nilotinib—KIT—Immune System—SOCS2—narcolepsy	0.000723	0.00262	CbGpPWpGaD
Nilotinib—BRAF—Downstream signaling in naïve CD8+ T cells—TNF—narcolepsy	0.000709	0.00257	CbGpPWpGaD
Nilotinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.000704	0.00256	CbGpPWpGaD
Nilotinib—CA12—Metabolism—CPT1B—narcolepsy	0.000689	0.0025	CbGpPWpGaD
Nilotinib—MAPK8—TNF alpha Signaling Pathway—TNF—narcolepsy	0.000689	0.0025	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—SOCS2—narcolepsy	0.000684	0.00248	CbGpPWpGaD
Nilotinib—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000673	0.00244	CbGpPWpGaD
Nilotinib—HCK—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.00066	0.0024	CbGpPWpGaD
Nilotinib—CA9—Metabolism—CHKB—narcolepsy	0.000653	0.00237	CbGpPWpGaD
Nilotinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—narcolepsy	0.000639	0.00232	CbGpPWpGaD
Nilotinib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—TNF—narcolepsy	0.000638	0.00232	CbGpPWpGaD
Nilotinib—MAPK8—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.000634	0.0023	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—SOCS2—narcolepsy	0.000616	0.00224	CbGpPWpGaD
Nilotinib—MAP4K1—MAPK Signaling Pathway—TNF—narcolepsy	0.000612	0.00222	CbGpPWpGaD
Nilotinib—LYN—Immune System—SOCS2—narcolepsy	0.000603	0.00219	CbGpPWpGaD
Nilotinib—ABL1—Immune System—SOCS2—narcolepsy	0.000601	0.00218	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.000596	0.00216	CbGpPWpGaD
Nilotinib—MAPK14—Cardiac Hypertrophic Response—TNF—narcolepsy	0.000591	0.00215	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—SOCS2—narcolepsy	0.000572	0.00208	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—CTNNBL1—narcolepsy	0.000569	0.00206	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.000557	0.00202	CbGpPWpGaD
Nilotinib—CA4—Metabolism—CPT1B—narcolepsy	0.00055	0.002	CbGpPWpGaD
Nilotinib—PDGFRA—Allograft Rejection—TNF—narcolepsy	0.000529	0.00192	CbGpPWpGaD
Nilotinib—CA2—Metabolism—CPT1B—narcolepsy	0.000527	0.00191	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HCRTR2—narcolepsy	0.00051	0.00185	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HCRTR1—narcolepsy	0.00051	0.00185	CbGpPWpGaD
Nilotinib—MAPK11—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.000505	0.00183	CbGpPWpGaD
Nilotinib—CA1—Metabolism—CPT1B—narcolepsy	0.000505	0.00183	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—HLA-DQA1—narcolepsy	0.000504	0.00183	CbGpPWpGaD
Nilotinib—MAPK8—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.000495	0.0018	CbGpPWpGaD
Nilotinib—LCK—Immune System—SOCS2—narcolepsy	0.000495	0.0018	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—P2RY11—narcolepsy	0.000493	0.00179	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HCRTR2—narcolepsy	0.000485	0.00176	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HCRTR1—narcolepsy	0.000485	0.00176	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—HLA-DQB1—narcolepsy	0.000472	0.00171	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—P2RY11—narcolepsy	0.000469	0.0017	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00046	0.00167	CbGpPWpGaD
Nilotinib—MAPK8—Apoptosis—TNF—narcolepsy	0.000454	0.00165	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000453	0.00164	CbGpPWpGaD
Nilotinib—CA9—Metabolism—CPT1B—narcolepsy	0.000444	0.00161	CbGpPWpGaD
Nilotinib—MAPK8—MAPK Signaling Pathway—TNF—narcolepsy	0.000425	0.00154	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.000424	0.00154	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000424	0.00154	CbGpPWpGaD
Nilotinib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.000421	0.00153	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HCRT—narcolepsy	0.000419	0.00152	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—HLA-DQA1—narcolepsy	0.000414	0.0015	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HCRTR2—narcolepsy	0.000407	0.00148	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HCRTR1—narcolepsy	0.000407	0.00148	CbGpPWpGaD
Nilotinib—MAP2K5—MAPK Signaling Pathway—TNF—narcolepsy	0.000405	0.00147	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HCRTR2—narcolepsy	0.000403	0.00146	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HCRTR1—narcolepsy	0.000403	0.00146	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HCRT—narcolepsy	0.000398	0.00145	CbGpPWpGaD
Nilotinib—MAPK11—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.000394	0.00143	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—P2RY11—narcolepsy	0.000393	0.00143	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CHKB—narcolepsy	0.000389	0.00141	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—P2RY11—narcolepsy	0.000389	0.00141	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—HLA-DQB1—narcolepsy	0.000387	0.0014	CbGpPWpGaD
Nilotinib—MAPK8—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000384	0.00139	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000375	0.00136	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—PENK—narcolepsy	0.000374	0.00136	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HCRTR2—narcolepsy	0.000367	0.00133	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HCRTR1—narcolepsy	0.000367	0.00133	CbGpPWpGaD
Nilotinib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—narcolepsy	0.000361	0.00131	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000359	0.0013	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—PENK—narcolepsy	0.000355	0.00129	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—P2RY11—narcolepsy	0.000354	0.00129	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HCRTR1—narcolepsy	0.000347	0.00126	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HCRTR2—narcolepsy	0.000347	0.00126	CbGpPWpGaD
Nilotinib—EPHB3—Developmental Biology—TNF—narcolepsy	0.000341	0.00124	CbGpPWpGaD
Nilotinib—BRAF—MAPK Signaling Pathway—TNF—narcolepsy	0.000336	0.00122	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—P2RY11—narcolepsy	0.000335	0.00122	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HCRT—narcolepsy	0.000334	0.00121	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HCRT—narcolepsy	0.000331	0.0012	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CHKB—narcolepsy	0.00033	0.0012	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000325	0.00118	CbGpPWpGaD
Nilotinib—BLK—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000322	0.00117	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TRH—narcolepsy	0.000318	0.00115	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000313	0.00114	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HCRTR2—narcolepsy	0.000313	0.00114	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HCRTR1—narcolepsy	0.000313	0.00114	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000308	0.00112	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HCRTR2—narcolepsy	0.000306	0.00111	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HCRTR1—narcolepsy	0.000306	0.00111	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000304	0.0011	CbGpPWpGaD
Nilotinib—EPHA3—Developmental Biology—TNF—narcolepsy	0.000304	0.0011	CbGpPWpGaD
Nilotinib—ABL2—Developmental Biology—TNF—narcolepsy	0.000304	0.0011	CbGpPWpGaD
Nilotinib—HCK—Immune System—HLA-DQA1—narcolepsy	0.000303	0.0011	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—P2RY11—narcolepsy	0.000302	0.0011	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TRH—narcolepsy	0.000302	0.0011	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HCRT—narcolepsy	0.000301	0.00109	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—PENK—narcolepsy	0.000298	0.00108	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—P2RY11—narcolepsy	0.000296	0.00107	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—PENK—narcolepsy	0.000295	0.00107	CbGpPWpGaD
Nilotinib—LCK—Cytokine Signaling in Immune system—HLA-DRB1—narcolepsy	0.000294	0.00107	CbGpPWpGaD
Nilotinib—EPHA8—Developmental Biology—TNF—narcolepsy	0.000293	0.00106	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HCRTR1—narcolepsy	0.00029	0.00105	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HCRTR2—narcolepsy	0.00029	0.00105	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—TNF—narcolepsy	0.00029	0.00105	CbGpPWpGaD
Nilotinib—EPHA4—Developmental Biology—TNF—narcolepsy	0.00029	0.00105	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000288	0.00105	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HCRT—narcolepsy	0.000285	0.00103	CbGpPWpGaD
Nilotinib—HCK—Immune System—HLA-DQB1—narcolepsy	0.000284	0.00103	CbGpPWpGaD
Nilotinib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—narcolepsy	0.000282	0.00102	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—TNF—narcolepsy	0.00028	0.00102	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—P2RY11—narcolepsy	0.00028	0.00102	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HRH3—narcolepsy	0.000279	0.00101	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000277	0.00101	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—HLA-DQA1—narcolepsy	0.000275	0.000997	CbGpPWpGaD
Nilotinib—BLK—Immune System—HLA-DQA1—narcolepsy	0.000275	0.000997	CbGpPWpGaD
Nilotinib—FGR—Immune System—HLA-DQA1—narcolepsy	0.000274	0.000994	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—TNF—narcolepsy	0.000272	0.000988	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000272	0.000986	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—PENK—narcolepsy	0.000268	0.000974	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HRH3—narcolepsy	0.000265	0.000961	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—CPT1B—narcolepsy	0.000265	0.00096	CbGpPWpGaD
Nilotinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000261	0.000948	CbGpPWpGaD
Nilotinib—PDGFRB—MAPK Signaling Pathway—TNF—narcolepsy	0.000261	0.000946	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—HLA-DQB1—narcolepsy	0.00026	0.000942	CbGpPWpGaD
Nilotinib—BLK—Immune System—HLA-DQB1—narcolepsy	0.000257	0.000933	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—HLA-DQB1—narcolepsy	0.000257	0.000933	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HCRT—narcolepsy	0.000257	0.000932	CbGpPWpGaD
Nilotinib—FGR—Immune System—HLA-DQB1—narcolepsy	0.000256	0.000929	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—TNF—narcolepsy	0.000256	0.000929	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000255	0.000924	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000254	0.000922	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—PENK—narcolepsy	0.000254	0.000922	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TRH—narcolepsy	0.000253	0.000919	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HCRT—narcolepsy	0.000251	0.000913	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HCRTR2—narcolepsy	0.000251	0.000911	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HCRTR1—narcolepsy	0.000251	0.000911	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TRH—narcolepsy	0.000251	0.00091	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—P2RY11—narcolepsy	0.000242	0.00088	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CHKB—narcolepsy	0.000242	0.000879	CbGpPWpGaD
Nilotinib—MAPK14—MAPK Signaling Pathway—TNF—narcolepsy	0.000242	0.000878	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HCRT—narcolepsy	0.000238	0.000865	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—TNF—narcolepsy	0.000236	0.000857	CbGpPWpGaD
Nilotinib—KIT—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000231	0.00084	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TAC1—narcolepsy	0.000231	0.000838	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—NPS—narcolepsy	0.000231	0.000838	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000229	0.000832	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PENK—narcolepsy	0.000229	0.000831	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TRH—narcolepsy	0.000228	0.000828	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—CPT1B—narcolepsy	0.000224	0.000815	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PENK—narcolepsy	0.000224	0.000813	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000223	0.000808	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HRH3—narcolepsy	0.000222	0.000805	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HRH3—narcolepsy	0.00022	0.000798	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TAC1—narcolepsy	0.000219	0.000796	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—NPS—narcolepsy	0.000219	0.000796	CbGpPWpGaD
Nilotinib—PDGFRA—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000219	0.000795	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HLA-DQA1—narcolepsy	0.000219	0.000794	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000218	0.000793	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TRH—narcolepsy	0.000216	0.000784	CbGpPWpGaD
Nilotinib—HCK—Immune System—HLA-DRB1—narcolepsy	0.000216	0.000783	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PENK—narcolepsy	0.000212	0.000771	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000208	0.000756	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HCRT—narcolepsy	0.000206	0.000748	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CHKB—narcolepsy	0.000205	0.000744	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HLA-DQB1—narcolepsy	0.000205	0.000743	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—TNF—narcolepsy	0.0002	0.000727	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HRH3—narcolepsy	0.0002	0.000726	CbGpPWpGaD
Nilotinib—KIT—Immune System—HLA-DQA1—narcolepsy	0.000197	0.000716	CbGpPWpGaD
Nilotinib—PDGFRB—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000197	0.000716	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—HLA-DRB1—narcolepsy	0.000195	0.000709	CbGpPWpGaD
Nilotinib—BLK—Immune System—HLA-DRB1—narcolepsy	0.000195	0.000709	CbGpPWpGaD
Nilotinib—FGR—Immune System—HLA-DRB1—narcolepsy	0.000195	0.000707	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TRH—narcolepsy	0.000195	0.000706	CbGpPWpGaD
Nilotinib—LYN—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000193	0.000701	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TRH—narcolepsy	0.000191	0.000692	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HRH3—narcolepsy	0.000189	0.000688	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HLA-DQA1—narcolepsy	0.000187	0.000678	CbGpPWpGaD
Nilotinib—KIT—Immune System—HLA-DQB1—narcolepsy	0.000185	0.00067	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TAC1—narcolepsy	0.000184	0.000667	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—NPS—narcolepsy	0.000184	0.000667	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PENK—narcolepsy	0.000184	0.000667	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TAC1—narcolepsy	0.000182	0.000661	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—NPS—narcolepsy	0.000182	0.000661	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TRH—narcolepsy	0.000181	0.000656	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CHKB—narcolepsy	0.000179	0.000648	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HLA-DQB1—narcolepsy	0.000175	0.000634	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HRH3—narcolepsy	0.000171	0.000619	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-DQA1—narcolepsy	0.000168	0.000611	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CHKB—narcolepsy	0.000168	0.000611	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HRH3—narcolepsy	0.000167	0.000606	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CHKB—narcolepsy	0.000167	0.000605	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TAC1—narcolepsy	0.000166	0.000602	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—NPS—narcolepsy	0.000166	0.000602	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-DQA1—narcolepsy	0.000165	0.000598	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—CPT1B—narcolepsy	0.000165	0.000597	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-DQA1—narcolepsy	0.000164	0.000595	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HRH3—narcolepsy	0.000158	0.000575	CbGpPWpGaD
Nilotinib—LCK—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000158	0.000575	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-DQB1—narcolepsy	0.000157	0.000571	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TAC1—narcolepsy	0.000157	0.00057	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—NPS—narcolepsy	0.000157	0.00057	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-DQA1—narcolepsy	0.000156	0.000567	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TRH—narcolepsy	0.000156	0.000567	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—HLA-DRB1—narcolepsy	0.000156	0.000565	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-DQB1—narcolepsy	0.000154	0.000559	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-DQB1—narcolepsy	0.000153	0.000557	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-DQB1—narcolepsy	0.000146	0.00053	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—TNF—narcolepsy	0.000143	0.000519	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—NPS—narcolepsy	0.000141	0.000513	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TAC1—narcolepsy	0.000141	0.000513	CbGpPWpGaD
Nilotinib—KIT—Immune System—HLA-DRB1—narcolepsy	0.00014	0.000509	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CPT1B—narcolepsy	0.000139	0.000506	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—HTR2A—narcolepsy	0.000139	0.000504	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TAC1—narcolepsy	0.000138	0.000502	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—NPS—narcolepsy	0.000138	0.000502	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HRH3—narcolepsy	0.000137	0.000497	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-DQA1—narcolepsy	0.000135	0.00049	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—HLA-DRB1—narcolepsy	0.000133	0.000482	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—HTR2A—narcolepsy	0.000132	0.000479	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—NPS—narcolepsy	0.000131	0.000476	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TAC1—narcolepsy	0.000131	0.000476	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-DQB1—narcolepsy	0.000126	0.000459	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CPT1B—narcolepsy	0.000121	0.000441	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—HLA-DRB1—narcolepsy	0.00012	0.000434	CbGpPWpGaD
Nilotinib—LYN—Immune System—HLA-DRB1—narcolepsy	0.000117	0.000425	CbGpPWpGaD
Nilotinib—ABL1—Immune System—HLA-DRB1—narcolepsy	0.000117	0.000423	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000114	0.000415	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TAC1—narcolepsy	0.000113	0.000412	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—NPS—narcolepsy	0.000113	0.000412	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CPT1B—narcolepsy	0.000113	0.000412	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—HLA-DRB1—narcolepsy	0.000111	0.000403	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—HTR2A—narcolepsy	0.000111	0.000402	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CHKB—narcolepsy	0.00011	0.000399	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—HTR2A—narcolepsy	0.00011	0.000398	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—TNF—narcolepsy	0.000108	0.000391	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—TNF—narcolepsy	0.000107	0.000389	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—TNF—narcolepsy	0.000102	0.000371	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—HTR2A—narcolepsy	9.97e-05	0.000362	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	9.89e-05	0.000359	CbGpPWpGaD
Nilotinib—LCK—Immune System—HLA-DRB1—narcolepsy	9.61e-05	0.000349	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—HTR2A—narcolepsy	9.44e-05	0.000343	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—HTR2A—narcolepsy	8.51e-05	0.000309	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—HTR2A—narcolepsy	8.33e-05	0.000302	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—HTR2A—narcolepsy	7.9e-05	0.000287	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CPT1B—narcolepsy	7.48e-05	0.000271	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—HTR2A—narcolepsy	6.83e-05	0.000248	CbGpPWpGaD
